A recent study suggests that individuals who discontinue new slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Findings released in a prominent health publication demonstrates that while overweight people often shed a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing these medications need to be cognizant of the risk of rapid rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to original weight in about a year and a half.
Analyzing Therapies
The study, which looked at dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
Researchers note that individuals who lose weight through lifestyle changes alone generally experience a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Doctors believe the mode of action of the jabs is key to understanding the heightened weight return.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels far above than normal could lead to the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication means hunger is unsuppressed, making overeating much more probable."
An Ongoing Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the high risk of weight regain, the therapy should be considered long-term.
This opinion is echoed by drug manufacturers, who state that the findings "highlight the persistent character of excess weight," similar to managing diseases like high blood pressure.
User Testimonies
Individuals who have discontinued the jabs explain a sudden return of appetite.
"It felt as if something that goes on and you become extremely hungry," said an individual.
This challenge is compounded if patients have not established lasting lifestyle or habit modifications during therapy.
Significant Use
Survey data indicate that a significant number of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is greater among women than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on combined lifestyle support.
